Regulation of GSK-3β by calpain in the 3-nitropropionic acid model

Hippocampus

Volumn 20, Issue 8, 2010, Pages 962-970

  Crespo Biel, N ^a,b   Camins, A ^a,b   Gutierrez Cuesta J ^a,b   Melchiorri, D ^c,d   Nicoletti, F ^c,e   Pallas M ^a,b   Canudas, Anna Maria ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

^e IRCCS NEUROMED   (Italy)

Author keywords

Calpeptin; Caspase; Cdk5; SB 415286; Spectrin

Indexed keywords

2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; 3 NITROPROPIONIC ACID; CALPAIN; CALPEPTIN; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; SERINE; 3 (3 CHLORO 4 HYDROXYPHENYLAMINO) 4 (4 NITROPHENYL) 1H PYRROLE 2,5 DIONE; 3-(3-CHLORO-4-HYDROXYPHENYLAMINO)-4-(4-NITROPHENYL)-1H-PYRROLE-2,5-DIONE; 3-NITROPROPIONIC ACID; AMINOPHENOL DERIVATIVE; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE; CONVULSANT AGENT; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MALEIMIDE DERIVATIVE; NEUROPROTECTIVE AGENT; NITRO DERIVATIVE; PEPTIDE CHLOROMETHYL KETONE; PROPIONIC ACID DERIVATIVE; PURINE DERIVATIVE; ROSCOVITINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CELL DEATH; CELL LEVEL; CELL LOSS; CONTROLLED STUDY; DEGENERATIVE DISEASE; EMBRYO; ENZYME ACTIVATION; ENZYME DEFECT; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HIPPOCAMPUS; INHIBITION KINETICS; MOLECULAR INTERACTION; MOUSE; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; MALE; METABOLISM; NERVE CELL; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; TIME;

AMINO ACID CHLOROMETHYL KETONES; AMINOPHENOLS; ANIMALS; CALPAIN; CASPASES; CELL SURVIVAL; CELLS, CULTURED; CONVULSANTS; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MALE; MALEIMIDES; MICE; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; PROPIONIC ACIDS; PURINES; RATS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 77954893946     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20691     Document Type: Article

References (40)

1. Akashiba H, Matsuki N, Nishiyama N. 2006. Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons. J Neurochem 99:733-744. (Pubitemid 44583433)
2. Akashiba H, Ikegaya Y, Nishiyama N, Matsuki N. 2008. Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid. J Biol Chem 283:6594-6606.
3. Alston TA, Mela L, Bright HJ. 1997. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci USA 74:3767-3771.
4. Battaglia F, Trinchese F, Liu S, Walter S, Nixon RA, Arancio O. 2003. Calpain inhibitors, a treatment for Alzheimer's disease: Position paper. J Mol Neurosci 20:357-362. (Pubitemid 38146994)
5. Beal MF. 2007. Mitochondria and neurodegeneration. Novartis Found Symp 287:183-192.
6. Bevers MB, Neumar RW. 2008. Mechanistic role of calpains in postischemic neurodegeneration. J Cereb Blood Flow Metab 28:655-673.
7. Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW, Lee CM. 2000. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 26:11074-11090.
8. Bizat N, Hermel JM, Boyer F, Jacquard C, Créminon C, Ouary S, Escartin C, Hantraye P, Kajewski S, Brouillet E. 2003a. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: Implications for Huntington's disease. J Neurosci 23:5020-5030.
9. Bizat N, Hermel JM, Humbert S, Jacquard C, Créminon C, Escartin C, Saudou F, Krajewski S, Hantraye P, Brouillet E. 2003b. In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: Implication of a calpain-mediated cleavage of active caspase-3. J Biol Chem 278:43245-43253.
10. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
11. Brouillet E, Guyot MC, Mittoux V, Altairac S, Condé F, Palfi S, Hantraye P. 1998. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794-805. (Pubitemid 28079371)
12. Brouillet E, Condé F, Beal MF, Hantraye P. 1999. Replicating Huntington's disease phenotype in experimental animals. Prog Neurobiol 59:427-468. (Pubitemid 29392967)
13. Brouillet E, Jacquard C, Bizat N, Blum D. 2005. 3-Nitropropionic acid: A mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 95:1521-1540. (Pubitemid 41804051)
14. Calabrese V, Scapagnini G, Giuffrida Stella AM, Bates TE, Clark JB. 2001. Mitochondrial involvement in brain function and dysfunction: Relevance to aging, neurodegenerative disorders and longevity. Neurochem Res 26:739-764. (Pubitemid 32756837)
15. Camins A, Verdaguer E, Folch J, Canudas AM, Pallàs M. 2006. The role of CDK5/P25 formation/inhibition in neurodegeneration. Drug News Perspect 19:453-460.
16. Canu N, Calissano P. 2003. In vitro cultured neurons for molecular studies correlating apoptosis with events related to Alzheimer disease. Cerebellum 2:270-278.
17. Cappuccio I, Calderone A, Busceti CL, Biagioni F, Pontarelli F, Bruno V, Storto M, Terstappen GT, Gaviraghi G, Fornai F, Battaglia G, Melchiorri D, Zukin RS, Nicoletti F, Caricasole A. 2005. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death. J Neurosci 25:2647-2657.
18. Chera B, Schaecher KE, Rocchini A, Imam SZ, Ray SK, Ali SF, Banik NL. 2002. Calpain upregulation and neuron death in spinal cord of MPTP-induced parkinsonism in mice. Ann N Y Acad Sci 965:274-280.
19. Chua BT, Guo K, Li P. 2000. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 275:5131-5135.
20. Crespo-Biel N, Camins A, Pelegrí C, Vilaplana J, Pallàs M, Canudas AM. 2007. 3-Nitropropionic acid activates calpain/cdk5 pathway in rat striatum. Neurosci Lett 421:77-81.
21. Crespo-Biel N, Camins A, Canudas AM. 2009. Evidence of calpain/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro. Neuropharmacology 56:422-428.
22. Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS, Melloni E, Przedborski S, Robertson GS, Anisman H, Merali Z, Park DS. 2003. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 23:4081-4091.
23. Di Rosa G, Odrijin T, Nixon RA, Arancio O. 2002. Calpain inhibitors: A treatment for Alzheimer's disease. J Mol Neurosci 19:135-141.
24. Franke TF, Kaplan DR, Cantley LC. 1997. PI3K: Downstream AKTion blocks apoptosis. Cell 88:435-437.
25. Gafni J, Ellerby LM. 2002. Calpain activation in Huntington's disease. J Neurosci 22:4842-4849.
26. Goñi-Oliver P, Lucas JJ, Avila J, Hernández F. 2007. N-terminal cleavage of GSK-3 by calpain: A new form of GSK-3 regulation. J Biol Chem 282:22406-22413.
27. Grimes CA, Jope RS. 2001. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65:391-426.
28. Hongisto V, Vainio JC, Thompson R, Courtney MJ, Coffey ET. 2008. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation- induced neuronal death. Mol Cell Biol 28:1515-1527.
29. Jope RS, Johnson GV. 2004. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95-102.
30. Karanian DA, Baude AS, Brown QB, Parsons CG, Bahr BA. 2006. 3-Nitropropionic acid toxicity in hippocampus: Protection through N-methyl-D-aspartate receptor antagonism. Hippocampus 16:834-842.
31. Nath R, Raser KJ, Stafford D, Hajimohammadreza I, Posner A, Allen H, Talanian RV, Yuen P, Gilbertsen RB, Wang KK. 1996. Nonerythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: Contributory roles of both protease families in neuronal apoptosis. Biochem J 319:683-690.
32. Pang Z, Bondada V, Sengoku T, Siman R, Geddes JW. 2003. Calpain facilitates the neuron death induced by 3-nitropropionic acid and contributes to the necrotic morphology. J Neuropathol Exp Neurol 62:633-643.
33. Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR. 1992. Glycogen synthase kinase-3: Functions in oncogenesis and development. Biochem Biophys Acta 16:147-162.
34. Polster BM, Basanez G, Etxebarria A, Hardwick JM, Nicholls DG. 2005. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem 280:6447-6454.
35. Ray SK, Wilford GG, Ali SF, Banik NL. 2000. Calpain upregulation in spinal cords of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease. Ann N Y Acad Sci 914:275-283.
36. Rickle A, Behbahani H, Ankarcrona M, Winblad B, Cowburn RF. 2006. PTEN, Akt, and GSK3beta signalling in rat primary cortical neuronal cultures following tumor necrosis factor-alpha and trans-4-hydroxy-2-nonenal treatments. J Neurosci Res 84:596-605.
37. Saltiel AR, Kahn CR. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806.
38. Stewart VC, Sharpe MA, Clark JB, Heales SJ. 2000. Astrocyte-derived nitric oxide causes both reversible and irreversible damage to the neuronal mitochondrial respiratory chain. J Neurochem 75:694-700.
39. Veeranna, Kaji T, Boland B, Odrljin T, Mohan P, Basavarajappa BS, Peterhoff C, Cataldo A, Rudnicki A, Amin N, Li BS, Pant HC, Hungund BL, Arancio O, Nixon A. 2004. Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: Relevance to Alzheimer's disease. Am J Pathol 165:795-805.
40. Wang KK. 2000. Calpain and caspase: Can you tell the difference? Trends Neurosci 23:59.